Liliana Bulfone has expertise in health technology assessment (HTA), including modelled economic evaluation. Lili has gained invaluable HTA skills and experience working in various sectors including government, academia, and as a consultant to the pharmaceutical industry. At ANU, Lili will be involved in delivery of the economic modelling component of the course in Health Technology Assessment.

Lili is a member (industry nominee) of the Life Saving Drugs Program (LSDP) Expert Panel, who provide advice to the Commonwealth Chief Medical Officer in relation to products funded through the LSDP.